Facile Synthesis of Colloidal Lead Halide Perovskite Nanoplatelets via Ligand-Assisted Reprecipitation
October 1st, 2019
This work demonstrates facile room-temperature synthesis of colloidal quantum-confined lead halide perovskite nanoplatelets by ligand-assisted reprecipitation method. Synthesized nanoplatelets show spectrally narrow optical features and continuous spectral tunability throughout the visible range by varying the composition and thicknesses.
This protocol demonstrates the room temperature synthesis of colloidal perovskite nanoplatelets for future optoelectronic applications. The main advantage of this approach is the compositional flexibility it provides. By making straightforward changes to the precursor mixtures, different perovskite nanoplatelets can be easily obtained.
Lead halide perovskites are uniquely suited to the ligand-assisted reprecipitation method. Unlike traditional semiconductors, the bonds within the perovskite crystal lattice can be easily broken and reformed at room temperature. To synthesize and equals to methylammonium lead bromide nanoplatelets, mix individual one milliliter volumes of the indicated 0.2 molar precursor solutions according to the table.
To synthesize and equals to methylammonium lead iodide nanoplatelets, mix individual one milliliter volumes of the indicated 0.2 molar precursor solutions according to the table. To synthesize nanoplatelets with mixed halide compositions, combine bromide only and iodide only perovskite nanoplatelet precursor solutions of the same thickness at the desired volumetric ratio for the target composition. For perovskite nanoplatelet synthesis, inject 10 microliters of each mixed precursor solution into individual 10 milliliter aliquots of toluene under vigorous stirring.
Leave the solutions under stirring for 10 minutes until no further color changes are observed to ensure a complete crystallization of each of the perovskite nanoplatelets. For general purification of the perovskite nanoplatelets, centrifuge the solutions at 2, 050 times g for 10 minutes and discard the supernatants. Then, re-disburse the nanoplatelets in an appropriate volume of solvent according to the planned downstream analysis with vortexing.
Pictures of colloidal perovskite nanoplatelet solutions under ambient and ultraviolet light combined with photoluminescence and absorption spectra further confirm the emissive and absorptive nature of the nanoplatelets. Transmission electron microscopy images and X-ray defraction patterns can be used to estimate the lateral dimensions and stacking spacings of the nanoplatelets, respectively, while also confirming their two-dimensional structures. Absorption spectra of perovskite nanoplatelet solutions with mixed halides demonstrate the tunability of the band gap.
Identical photoluminescence spectra from perovskite nanoplatelets with different ligands demonstrate the compositional flexibility of the organic surface capping species. It must be noted that the precise control of the ratios between individual precursors determines the thickness of the resulting nanoplatelets and ensures their thickness homogeneity. Following the synthesis and purification of the nanoplatelets, post-synthesis processes, such as thin film deposition, polymer encapsulation, and optoelectronic device fabrication can be performed depending on the planned usage.
One exciting feature of this synthetic method is its suitability for automated and high through-put experimentation, which can be used to quickly generate large data sets to train predictive computer models. Lead halides are believed to be carcinogenic and the inhalation of organic solvents and nanoparticles can be dangerous. Handle all of the chemicals in a well contained environment.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol demonstrates the room temperature synthesis of colloidal perovskite nanoplatelets for future optoelectronic applications. The main advantage of this approach is the compositional flexibility it provides.
Key Study Components
Area of Science
- Colloidal Nanoplatelets
- Optoelectronic Materials
- Perovskite Synthesis
Background
- Lead halide perovskites are uniquely suited to the ligand-assisted reprecipitation method.
- The bonds within the perovskite crystal lattice can be easily broken and reformed at room temperature.
- This method allows for the synthesis of various nanoplatelets by altering precursor mixtures.
- Room-temperature synthesis is advantageous for practical applications.
Purpose of Study
- To synthesize methylammonium lead bromide nanoplatelets.
- To explore the compositional flexibility in creating different perovskite nanoplatelets.
- To demonstrate a straightforward synthesis method for optoelectronic applications.
Methods Used
- Ligand-assisted reprecipitation method.
- Mixing individual one milliliter volumes of 0.2 molar precursor solutions.
- Adjusting precursor compositions to obtain desired nanoplatelet characteristics.
- Characterization of optical features and spectral tunability.
Main Results
- Synthesized nanoplatelets exhibit spectrally narrow optical features.
- Continuous spectral tunability throughout the visible range.
- Different compositions and thicknesses yield various optical properties.
- Successful demonstration of room-temperature synthesis.
Conclusions
- The ligand-assisted reprecipitation method is effective for synthesizing perovskite nanoplatelets.
- This approach offers significant compositional flexibility.
- Results indicate potential for future optoelectronic applications.
Frequently Asked Questions
Executive Industry Relevance
This method enables rapid, room-temperature synthesis of compositionally tunable colloidal perovskite nanoplatelets, supporting early-stage optoelectronic material discovery. The ligand-assisted reprecipitation approach provides a scalable, flexible platform for generating diverse nanoplatelet libraries with tunable band gaps across the visible spectrum. This facilitates predictive modeling and high-throughput screening for photovoltaic, LED, and sensor applications in biopharma-adjacent optoelectronic research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of structure-property relationships in halide perovskites through precise control of composition and thickness.
- Operational Value: Supports rapid generation of material variants for functional screening in optoelectronic assays.
Screening & Assay Development
- Scientific Value: Produces emissive, quantum-confined nanoplatelets with narrow photoluminescence peaks suitable as fluorescent probes or sensing elements.
- Operational Value: Yields colloidally stable dispersions compatible with downstream optical characterization and device integration workflows.
Translational & Preclinical Research
- Scientific Value: Enables exploration of halide-dependent optoelectronic properties relevant to bioimaging and photodynamic therapy platforms.
- Operational Value: Facilitates synthesis of ligand-functionalized nanoplatelets for surface modification and biocompatibility studies.
Pipeline & Workflow Integration
The method fits within early discovery workflows for optoelectronic material screening, enabling rapid iteration before preclinical device integration.
- Discovery Biology: Supports hypothesis testing on how halide composition and quantum confinement affect optical emission and absorption profiles.
- Screening: Generates standardized nanoplatelet dispersions with reproducible size and optical properties for parallel compound or condition evaluation.
- Analytics: Provides quantifiable outputs via photoluminescence peak position, absorption onset, and PL quantum yield for structure-activity correlation.
- Translational Research: Enables continuity from nanoplatelet synthesis to thin-film deposition and device fabrication for proof-of-concept optoelectronic prototypes.
- Enterprise Reuse: The ligand-assisted reprecipitation platform is adaptable to multiple halide and cation systems, supporting reuse across projects targeting different emission wavelengths.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in optoelectronic behavior through tunable band gap and emissive properties.
- Operational Value: Room-temperature synthesis, simple purification via centrifugation, and compatibility with common organic solvents.
- Strategic Value: Reduces material development timelines by enabling rapid compositional screening without high-temperature processing.
- Portfolio Impact: Supports risk-adjusted prioritization of nanoplatelet formulations based on emission wavelength, stability, and quantum yield for downstream optoelectronic investment.
Implementation Considerations
- Expertise in nanomaterial synthesis, solvent handling, and optical characterization (PL, UV-Vis).
- Access to centrifuge, vortexer, and inert atmosphere or fume hood for handling DMF and toluene.
- Standardization of precursor concentrations and mixing ratios to ensure thickness and composition homogeneity.
- Adaptation considerations for different ligand systems to maintain colloidal stability across varying polarities.
- Practical limitations include toxicity of lead precursors and organic solvents, requiring containment and waste management protocols.
